Biocomposites INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$890Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
3,721clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $206K
2020 $48K
2021 $108K
2022 $113K
2023 $100K
2024 $139K
2025 $176K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery $394K
Orthopaedic Trauma $114K
Adult Reconstructive Orthopaedic Surgery $105K
Foot & Ankle Surgery $73K
Plastic Surgery $48K
Podiatrist $23K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Gerhard Maale Plano, TX Orthopaedic Surgery $112,846.94
Adam Sassoon Los Angeles, CA Adult Reconstructive Orthopaedic Surgery $73,127.52
Stephen Quinnan West Palm Beach, FL Orthopaedic Surgery $47,114.33
Edward Mcpherson Los Angeles, CA Orthopaedic Surgery $40,173.34
Christopher Demas Albuquerque, NM Plastic Surgery $39,637.51
Daniel Schlatterer Atlanta, GA Orthopaedic Trauma $32,162.35
Robert Wetzel Cleveland, OH Orthopaedic Trauma $26,154.77
Motasem Refaat Clovis, CA Orthopaedic Trauma $19,290.16
Ilya Bendich Saint Louis, MO Adult Reconstructive Orthopaedic Surgery $18,635.68
Timothy Alton Renton, WA Orthopaedic Surgery $17,828.08

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.